Table 3 Data collection and measurements for healthy controls and potentially cross-reactive controls
From: Validation of cellular tests for Lyme borreliosis (VICTORY) study
|  | Baseline | 3 months |
|---|---|---|
Written information and informed consent | X | Â |
Baseline characteristics | X | Â |
Recording adverse events | X | X |
Laboratory measurements | ||
 B. burgdorferi s.l. serology | X |  |
 Spirofind Revised | X |  |
 QuantiFERON-LB | X |  |
 iSpot Lyme | X |  |
 LTT-MELISA | X |  |